MIMS UKfremanezumabmigraineMDDmajor depressive disorder
…ther CGRP pathway mAbs: 52%) and drug/administration costs from MIMS UK and the National Schedule of National Health Service costs, 202…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: MIMS UK ×
MIMS UK
This funder is selected. Its supporting articles are shown below.